day 1 agenda

Challenges and Advancements in Cardiology: Cardio World Congress 2024 (WCAC-2024)
June 25–26, 2024, at Hotel Duo, Prague, Czech Republic
Final Program
Day-1: June 25, 2024
08:00-08:40  Registrations 
08:40-09:00 Welcome Ceremony
       Keynote Session
09:00-09:30 Chronic Thromboembolic Pulmonary Hypertension (CTEPH) : A Frequently Overlooked Deadly Disease
Patrick M Honore, UCL Louvain Medical School, Belgium
09:30-10:00 Relaxin suppresses atrial fibrillation, reverses fibrosis and reduces inflammation in aged hearts
Guillermo Romero, University of Pittsburgh, USA
10:00-10:30 Surgery for severe congenital heart diseases in children from developing nations
Francois Lacour-Gayet, Marie Lannelongue Hospital, France
Group Photo @ Foyer (or) Hall
10:30-10:50  Refreshment Break @ Foyer
Technical Session-I
Themes: Cardiovascular Diseases and Disorders & Cardiovascular Imaging and Analysis
Session Chairs: Prof. Thomas Bernd Dschietzig & Prof. Guillermo Romero
10:50-11:10 Relation of Cardiorenal Syndrome to Mitral and Tricuspid Regurgitation in Acute Decompensated Heart Failure
Frank Seghatol-Eslami, Washington University School of Medicine, USA
11:10-11:30 Modulating immune cell metabolism to prevent post-vascular injury neointimal hyperplasia
Gustavo Enrique Crespo-Avilan, DUKE-NUS, Singapore
11:30-11:50 Soluble endoglin reduces thrombus formation and platelet aggregation via interaction with αIIbβ3 integrin
Elisa Rossi, University of Paris, France
11:50-12:10 Sublingual Varices and Arterial Hypertension
Christian Klein, University of Bonn, Germany
12:10-12:30 Utility of massive screening data to detect under diagnosed and minority diseases associated with high cardio-vascular risk. Project “Second chance”
Guillem Paluzie, Maresme y la Selva Health Corporation, Spain
12:30-12:50 Cardiovascular safety of prucalopride in patients with chronic idiopathic constipation (CIC)
Ashraf Youssef, Takeda, USA
12:50-13:10 Coronary microvascular dysfunction: Pathophysiology, clinical implications, and potential therapeutics
Ha Thanh Nguyen, University of Adelaide, Australia
13:10-14:00 Lunch @ Restaurant
Technical Session-II
Themes: Research and Advances in Cardiology & Neurology and Cardiology
Session Chairs: Prof. Francois Lacour-Gayet & Prof. Elena G. Tolkacheva
14:00-14:20 Electrical Burden as a Novel Marker of Atrial Fibrillation Instability and Development of the Complexity AF Score
Elena G. Tolkacheva, University of Minnesota, USA
14:20-14:40 Treatment Effects of Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Stratified by REVEAL Risk Score: Results from PADN-CFDA Trial
Shao-Liang Chen Chen, Nanjing First Hospital, Nanjing Medical University, China
14:40-15:00 Impact of high frequency stimulation to confirm a complete box isolation in catheter ablation of non-paroxysmal atrial fibrillation
Shun Kikuchi, Nagoya Tokushukai General Hospital, Japan
15:00-15:20 Postoperative elevated cardiac troponin levels predict all-cause mortality and major adverse cardiovascular events following noncardiac surgery: A dose-response meta-analysis of prospective studies dose-response meta-analysis of prospective studies
Qian Li, Fuwai Hospital, China
15:20-15:40 Left Ventricular Assist Device Optimization
Lola Xie, Baylor College of Medicine, USA
15:40-16:00 Refreshment Break @ Foyer
16:00-16:20 Diagnostic Sensitivity of Unenhanced CT for Cerebral Venous Thrombosis: Can Clot Density Measurement Replace CT Venogram?
Akash Ganguly, Warrington & Halton Teaching Hospitals, NHS FT, UK
16:20-16:40 Slot available
16:40-17:00 Spontaneous coronary artery dissection with leucoencephalopathy associated with thrombospondin Type 1 domain containing 1 gene mutation a case report
Gotabhaya Ranasinghe, National Hospital of Sri Lanka, Sri Lanka
                        Pannel Discussions
We are still accepting abstracts. To book your slot, contact Dr. Michael Alan at michael_alan@cardio-worldcongress.org

day 2 agenda

Challenges and Advancements in Cardiology: Cardio World Congress 2024 (WCAC-2024)
June 25–26, 2024, at Hotel Duo, Prague, Czech Republic
Final Program
Day-2: June 26, 2024
       Keynote Session
09:00-09:30 State of the Heart of Cardiac cell therapy
Philippe R.G. Henono, Cell Prothera SAS, France
09:30-10:00 Natriuretic peptides and cardiac troponins as predictors of early stages of heart failure in patients with type 2 diabetes
Petr Jarolim, Brigham and Women's Hospital, Harvard Medical School, USA
Technical Session-III
Themes: Cardiovascular Pharmacology & Diabetes, Hypertension and Obesity
Session Chairs: Prof. Ashraf Youssef
10:00-10:20 The development of human relaxin-2 for Heart Failure with preserved Ejection Fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
10:20-10:40 Pulse wave analysis measurements: important, underestimated and undervalued parameters in cardiovascular health problems
Louis Claessens, Catholic University of Leuven, Belgium
10:40-11:00 Low-dose Olaparib improves septic cardiac function by reducing ferroptosis via accelerated mitophagy flux
Fengjuan Li, The First Affiliated Hospital of Jinan University, China
11:00-11:20 Refreshment Break @ Foyer
11:20-11:40 Cerebral safety evaluation using MRI of the Valvosoft Non-Invasive Ultrasound Therapy for 10 patients with severe symptomatic aortic valve stenosis
Danijela Trifunovic-Zamaklar, University Clinical Center of Serbia, Serbia
11:40-12:00 Large intercoronary communication between the right coronary artery and the left circumflex artery in patient with late stent thrombosis
Xhevdet Krasniqi, University of Prishtina "Hasan Prishtina", Albania
12:00-12:20 Extraction of stylet-driven pacing lead for left bundle branch area pacing
Paolo Bonfanti, Valduce Hospital, Italy
12:20-12:40 Pediatric nurse practitioners in adult congenital heart disease care 
Rebecca Byars, The University of Texas Dell Medical School, USA
12:40-13:00 Quadricuspid Aortic Valve and Rheumatoid Arthritis: Is There a Connection?
Aurora Bakalli, University Clinical Center of Kosova, Albania
13:00- 14:00 Lunch @ Restaurant
   
14:00-14:40 Poster Viewing
Technical Session-IV
Session Chairs: TBA
14:40-15:00 CV-PREVITAL: a large-scale real-world trial evaluating the effectiveness of a digital intervention for primary cardiovascular prevention
Mauro Amato, Centro Cardiologico Monzino, IRCCS, Italy
15:00-15:20 Slot available
15:20-15:40 The health-related quality of life measured with EQ-5D-5L in Italian people affected by cardiovascular disease
Francesco Malandrini, SDA Bocconi, Italy
15:40-16:00 Refreshment Break @ Foyer
16:00-16:20 Slot available
16:20-16:40 Clinical outcomes of revascularization with percutaneous coronary intervention prior to transcatheter aortic valve replacement: a comprehensive meta-analysis
Ahmed Altibi, Oregon Health & Science University, USA
16:40-17:00 Automatic Classification of Heart Failure Based on Cine-CMR Images
Yuan Xie, Shanghai Jiao Tong University, China

posters agenda

Poster Presentations
Day 2: June 26, 2024  (14:00–14:40)
P-1 Associations between Hypertension and Diabetes Risk: Metabolic Screening in a Brazilian State
Deise Maria Rego Rodrigues Silva, Federal University of Sergipe, Brazil
P-2 Quality assessment of a scientific journal–an example of Cardiology Journal
Lukasz Stolarczyk, Via Medica Publishers, Poland
P-3 Potential targets for the treatment of MI: GRP75-mediated Ca2+ transfer in MAM
Li Yu, Nanjing university of Chinese Medicine, China
P-4 Evaluating the Effects of a Novel Strength Training Program in Remote Cardiological Rehabilitation: A Shift from Aerobic Dominance - A Pilot Randomized Controlled Trial
Irene Nabutovsky, Sheba medical center, Israel
P-5 Slot available
P-6 Modulation Of Monocyte Subtypes, Chemokine Receptors And Circulating Microparticles After Physical Training In Obese Individuals
Carolina Nunes Franca, Santo Amaro University, Brazil
P-7 Treatment of atrio-esophageal fistula following epicardial ablation for atrial fibrillation
David W. Yaffee, Hartford HealthCare Heart and Vascular Institute, USA

Challenges and Advancements in Cardiology: Cardio World Congress 2024 (WCAC-2024)
June 25–26, 2024, at Hotel Duo, Prague, Czech Republic
Virtual session: June 26, 2024 (Central European Time)
WCAC-2024 Adrenal Medullary Hyperplasia: A systematic review and meta-analysis
Rafal Ganni, University of Notre Dame, Sydney, Australia
WCAC-2024 Comparative study of photoplethysmographic waveforms with application of antihypertensive medication in hypertensive patients
Yanchun Hu, The 5th people 's hospital of Jinan, China
WCAC-2024 SAH and SAM/SAH ratio associate with acute kidney injury in critically ill patients: A case-control study
Xiaona Li, Peking University Third Hospital, China
WCAC-2024 Enhancing Hypercholesterolemia Management: The Promise of Bempedoic Acid
Yi Li, No. 1 Hospital Of Baoding, China
WCAC-2024 Reversed Septal Curvature Is Associated With Nonsustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy
Jianzhong Zhou, The First Affiliated Hospital of Chongqing Medical University, China
WCAC-2024 Slot available
WCAC-2024 Atherosclerosis Plaque Reduction by Lycopene Is Mediated by Increased Energy Expenditure through AMPK and PPARα in ApoE KO Mice Fed with a High Fat Diet
Giovanni Pallio, University of Messina, Italy
WCAC-2024 Antiphospholipid Antibodies and Vascular Thrombosis in Patients with Severe Forms of COVID-19
Mirjana Zlatkovic Svenda, Faculty of Medicine, University of Belgrade, Serbia; University of East Sarajevo, Foca, BiH
WCAC-2024 Toward a coupled heart-lung multiscale multiphysics mechanical model
Milos Kojic, Houston Methodist Research Institute, Serbia
WCAC-2024 Analysis of the Model of Atherosclerosis Formation in Pig Hearts as a Result of Impaired Activity of DNA Repair Enzymes
Pawel Kowalczyk, The Kielanowski Institute of Animal Physiology and Nutrition, Poland
WCAC-2024 25in25
Lisa Anderson, St George's Hospital, London, United Kingdom
WCAC-2024 Role of Cardiac MRI in detecting Partial anomalous pulmonary venous return (PAPVR)
Ashwin Ajay, Wirral University Teaching Hospital, United Kingdom
WCAC-2024 Slot available
WCAC-2024 Getting to the heart of the matter: integration of exercise into cardio-oncology care
Christina Dieli-Conwright, Dana-Farber Cancer Institute / Harvard Medical School, USA
WCAC-2024 Non-radiation based mechanical thrombectomy for lower extremity deep vein thrombosis
Eugene Ichinose, Oklahoma Heart Institute, USA
WCAC-2024 Cardionephrology Service : Need of the hour
Nupur Uppal, Zucker School of Medicine at Hofstra/Northwell, USA
WCAC-2024 Discovery of a safe GIRK1/4 inhibitor for pharmacological cardioversion of atrial fibrillation
Stefan Peukert, Novartis Biomedical Research, USA
WCAC-2024 Gut microbial metabolic pathways as opportunities for new therapeutic strategies in cardiometabolic diseases
Ina Nemet, Cleveland Clinic, USA
WCAC-2024 Characterizing deficient myoblast fusion in peripheral arterial disease (PAD)
Ulka Sachdev, University of Pittsburgh Medical Center, USA
WCAC-2024 Chronic thoracic pain after cardiac surgery: role of inflammation and biomechanical sternal stability
Jeko M. Madjarov, UNC at Chapel Hill, NC, USA
WCAC-2024 Acupuncture after valve surgery is feasible and shows promise in reducing post-operative atrial fibrilation: The ACU-Heart pilot trial
Kim Feingold, Northwestern University, USA

Download